JOIN OUR USA EAST COAST 2018 STRATEGY MEETING
13th June 2018 | The Sheraton, Boston Harbour
OUR UNIQUE FORMAT
These interactive and informal discussion groups are the hallmark of the meeting. Small exclusive groups of leaders who face shared challenges and strategic priorities are brought together in 60-minute sessions that enable participants to share ideas and lessons learned. Facilitated by experienced professionals, these sessions provide a valuable dialogue with peers on current challenges and topical issues. Each discussion group has limited numbers which ensures each delegate is given ample opportunity to raise questions and contribute to the discussion.
Thought leaders who will benefit from attending include CXOs, EVPs, SVPs, VPs, Executive Directors, Directors and Global Heads responsible for:
– Clinical Trials Supply Chain, Clinical Drug Supply, Biologics Supply Chain, Brand Safety & Security, Technical Operations and Manufacturing, Investigational Material Supply Chain, Product Research and Development, Clinical Supply Strategic Resource & Portfolio Management, Clinical Supplies Quality, Regional Clinical Trial Management, Global Clinical Supply, Clinical Supply Chain Operations, Clinical Supply Logistics.
Matthew PlaudChief Executive Officer, SOTIO
Frank LeuChief Executive Officer
Alan SmithExecutive Vice President, Technical Operations
Bellicum Pharmaceuticals, Inc.
Luisa Freitas Dos SantosVice President Target to Patient Supply Chain, GlaxoSmithKline
Product Development and Supply - PTS R&D,
Rosa NotarobertoVice President, US Operations
Janelle SaboGlobal Head, Product Delivery
Eli Lilly and Company
Alexander DebetsHead Global Clinical Supply
Eva-Maria MuchitschHead GMP Clinical Quality Technical Operations
WHAT TO EXPECT
Interactive Roundtable Discussions
Attendees can proactively share and ask questions to their peers about the success of their work in an informal setting.
Director level one-to-one meetings
We provide opportunities to engage with one another in our strategy meeting in a series of pre-arranged business meetings by interacting face to face.
Tailor-fit and Personalized Agenda
Being able to experience different sessions is what makes our event unique that’s why our attendees can personalize and select sessions they want to participate in.
Several networking opportunities are in store for attendees to connect and build new relationships with their peers through luncheons, cocktails and informal introductions.
Thank you for reaching Proventa International
Our unique strategy meeting platform ensures that delegates can network with peers and benchmark their challenges whilst meeting a select number of supplier organizations that are currently at the forefront of innovation. This in turns helps them to save time and money associated in sourcing the best suppliers to procure solutions in an environment, which is 100% conducive to doing business.
If you are an exciting start-up trying to get your innovation in front global heads from the leading Pharmaceutical companies, or a mature market-leading conglomerate with legacy solutions trying to stay one step ahead of the competition – we are here to help!
WHAT PEOPLE SAY
Clinical Trial Supply Chain Strategy Meeting US East Coast 2016,
Pharma Supply Chain EU 2016 , Return on Investment attained at the meeting and why they are coming back
Chief Information Officer
Its nice because they basically allowed people to engaged to discussions and questions. Academic and industry is very nice and informative
Ivan John Clement
Data Scientist - R&D
Its good because you really get the people to talk. They are willing to share their knowledge, the juniors are very eager to learn.
Manager Quality Assurance
The format is the beginning of breakthrough and integration, the level of delegates is very good and excellent, they learn a lot.
Founder & President
The kind of interaction is very interactive
Director & Professor
Because of diversity we really districts the points and all. People are very diversity and thoughtful in a round table.
Images coming soon
39 Dalton St, Boston, MA 02199, USA
OUR MEDIA PARTNERS
Chief Executive Officer, SOTIO, LLC
Matthew L. Plaud is an accomplished executive with over twenty years of experience in a highly regulated environment. Currently he is the CEO of SOTIO, LLC, the North American arm of the SOTIO Group. In his time with SOTIO, he has risen through the ranks from starting as the Director of Apheresis Network Management, to taking on all aspects of Logistics, to ultimately being promoted to the CEO of the US operation. As CEO he has improved staff moral while enacting major savings programs.
Chief Executive Officer, Novapeutics
Frank Leu is a Co-Founder and CEO of Novapeutics located in Philadelphia, developing a first-in-class insulin-producing beta-cell restoration curative for diabetes. Prior, Frank was at a specialty pharma, Verto Institute, developing curatives for a neuroendocrine cancer. Frank received his Pharmacology Ph.D. from Weill Cornell Graduate School of Medical Sciences, postdoc-ed at a HHMI lab at the Rockefeller University, and served as an instructor at the Rutgers Cancer Institute of NJ. Currently, he is an adjunct professor at Thomas Jefferson University, advisor to 1776 for Pennovation Center Labs, founder of BioPharMatrix (life-science ecosystem), and serving on numerous life-sciences advisory boards.
Executive Vice President, Technical Operations, Bellicum Pharmaceuticals, Inc.
Luisa Freitas Dos Santos
Vice President Target to Patient Supply Chain, GlaxoSmithKline
Product Development and Supply - PTS R&D
Vice President, US Operations, Takeda Oncology
Global Head, Product Delivery, Eli Lilly and Company
Head Global Clinical Supply, Merck
Alexander Debets currently serves as Associate Vice President and Global Head of Clinical Supply Chain at Merck. Mr. Debets has 25 years of experience managing a global clinical supply chain, including the planning, manufacturing, packaging and distribution of clinical medication, and expertise in pharmaceutical, chemical and (bio-) analytical of a broad range of pharmaceutical products (active ingredients, solid and non-solid formulations).
Head GMP Clinical Quality Technical Operations, Shire